Endoscopic improvements with filgotinib are consistent with clinical remission rates in patients with Crohn's disease

MECHELEN Belgium Sept. 25 2016 GLOBE NEWSWIRE Galapagos NV Euronext & NASDAQ GLPG reports that Dr Severine Vermeire principal investigator of the FITZROY Phase 2 study with investigational agent filgotinib in Crohn's disease will present endoscopi...